Work

Adebrelimab Combined with Chemotherapy for Esophageal Neuroendocrine Carcinoma: A Case Report

Year: 2026

Type: article

Abstract: Introduction: Esophageal neuroendocrine carcinoma is an extremely rare type of esophageal cancer. Due to the limited number of cases, there are no established diagnostic and treatment guidelines. Case Presentation: A 60-year-old male presented with dysphagia and was subsequently diagnosed with large cell neuroendocrine carcinoma of the esophagus. He received four cycles of treatment with adebrelimab combined with etoposide and carboplatin, which resulted in significant tumor shrinkage. Conclusion: Esophageal neuroendocrine carcinoma is a highly malignant tumor with a high mortality rate. A better understanding of its diagnosis and treatment strategies may contribute to favorable trends in patient outcomes, while its actual effect on long-term prognosis remains to be validated with extended follow-up.

Source: Case Reports in Gastroenterology

DOI: 10.1159/000550931

Authors: Yan-ge Zhao, Tong Zhao, Kun Ma, Shao-xuan Wang

Institutions: Jining Medical University, Jining First People's Hospital

Language: English

Topic: Esophageal Cancer Research and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,030